Recombinant SchizosaccharoMyces pombe ppa2 Protein，His & Myc

PPA2, or Phosphoenolpyruvate Carboxykinase 2, is an essential enzyme in the gluconeogenesis metabolic pathway, predominantly expressed in liver and kidney tissues. Its primary role is to facilitate the conversion of oxaloacetate to phosphoenolpyruvate, utilizing GTP as a cofactor, which is crucial for maintaining glucose homeostasis, especially during fasting and in diabetic conditions. Dysregulation of PPA2 has been linked to metabolic disorders, including type 2 diabetes and obesity, making it a significant target for therapeutic interventions. Researchers are increasingly focusing on the recombinant expression of PPA2 to explore its structure, function, and potential as a drug target. By producing PPA2 in a laboratory setting, scientists can obtain large quantities of the enzyme for detailed biochemical characterization and to investigate its interactions with other metabolic regulators. This recombinant protein can also serve as a valuable tool for screening inhibitors that may help in correcting metabolic imbalances. Understanding PPA2's role at the molecular level could provide insights into its regulatory mechanisms and pave the way for developing novel strategies for managing metabolic diseases. As the prevalence of such disorders continues to rise globally, research on PPA2 and its recombinant protein holds promise for contributing to better therapeutic solutions and improving patient outcomes in metabolic health.